Comments
Loading...
Kintor Pharmaceutical Analyst Ratings and Price Targets | OTC:KNTPF | Benzinga
Kintor Pharmaceutical Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Kintor Pharmaceutical Corp from these most-recent analyst ratings.
Analyst Ratings for Kintor Pharmaceutical
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Kintor Pharmaceutical (KNTPF) stock?
There is no price target for Kintor Pharmaceutical
What is the most recent analyst rating for Kintor Pharmaceutical (KNTPF)?
There is no analyst for Kintor Pharmaceutical
When was the last upgrade for Kintor Pharmaceutical (KNTPF)?
There is no last upgrade for Kintor Pharmaceutical
When was the last downgrade for Kintor Pharmaceutical (KNTPF)?
There is no last downgrade for Kintor Pharmaceutical.
When is the next analyst rating going to be posted or updated for Kintor Pharmaceutical (KNTPF)?
There is no next analyst rating for Kintor Pharmaceutical.
Is the Analyst Rating Kintor Pharmaceutical (KNTPF) correct?
There is no next analyst rating for Kintor Pharmaceutical.
Browse analyst ratings and price targets on all stocks.